Sana Biotechnology Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +182,500.0% | +224.3% | +87.0% | +41.1% | +57.2% | -36.9% | -17.7% | |
| – | +1,168.6% | +289.3% | +283.7% | +71.4% | -7.3% | +6.0% | -32.4% | |
| – | +27,800.0% | +310.8% | -62.2% | -49.8% | – | – | – | |
| – | – | -41.5% | +59.2% | -23.0% | +146.8% | -106.4% | – | |
| – | +5,592.0% | -8.8% | +25.1% | -30.1% | -4.0% | +66.9% | -97.2% | |
| – | +11,164.2% | +187.5% | -2.7% | – | -18.3% | -89.9% | -330.6% | |
| – | – | – | – | -99.9% | – | – | – | |
| – | – | – | – | – | – | -71.3% | +1,527.8% | |
| – | +389.3% | +94.7% | +45.0% | -99.2% | +544.1% | +531.2% | -35.6% | |
| – | +60.2% | -10.4% | +198.8% | -155.3% | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.